Shenyang 2016.7 fifteenth annual Asia Nuclear Medicine Conference and the seven China Japan Korea Nuclear Medicine annual meeting
views：time：2016-12-07 17:17:06
In July 14, 2016, the fifteenth Asian nuclear medicine annual meeting and the seventh session of the China Nuclear Medicine annual meeting held on the occasion, the nuclear medicine branch of interventional radionuclide targeting and accurate treatment work of the committee was set up in Shenyang of the Chinese Medical Association, chaired by Professor Zhang, the Chinese Medical Association of nuclear medicine branch director Professor Li Yaming to visit.
Professor Feng first announced the composition of the working committee. From the number of experts with rich experience of interventional radionuclide therapy is composed of the working committee of the Hunan Provincial Tumor Hospital (Hospital of Xiangya Medical College of Central South University affiliated) Professor Shi Feng served as chairman of the committee, Southwest Hospital of Third Military Medical University Professor Huang school full of Shanghai No.6 People's Hospital, Professor Luo Quanyong, Professor Yang Hui Henan Cancer Hospital, Huashan Hospital of Fudan University, Professor Liu Xing party deputy the chairman of the committee, Professor Li Yaming, Professor Li Sijin, Professor Kuang Anren and Professor Chai Shude as a consultant. Chen Zhijun, Cha Jinshun, Cui Yali, Chen Xiaoliang, Deng Zhiyong, Fu Wei, Fu Peng, East, Huang Dingde, Huang Ruixue, Huang Rui and He Yujie, He Lirong, Hu Shuo, Li Suping, Li Lei, Li Shaohua, Li Zhi, Li Gang, Yuan Gengbiao, Yang Shijian, Yang Fu Zhou, Qin, Guangqing stone Yongde, Wang Yang, Wang Feng, Wu Yu, Xue Jianjun day, Zeng Li, Zhang Qing, Zhang Lele, Zhang Chunyin, Zhao Chunlei, Zhu Gaohong, Zhou Xin, Zhou Haizhong, Zheng Feibo was elected as a member of. The Committee for nuclear interventional and targeted therapy of the nuclear medicine branch of the Chinese Medical Association consists of 42 members.
Chairman Li Yaming standing in the subject position and development prospect of nuclear medicine development, the height of the Working Committee hopes to hope that the working group will combine our interventional radionuclide and the present situation of accurate treatment, actively promote the National Planning Commission to promote the spirit of the accurate treatment of tumors, the standard treatment of radionuclides, promotion of radionuclide therapy. Construction, enhance the interventional radionuclide therapy status in tumor treatment, so that more patients can receive standard and effective treatment.
Professor Shifeng delegate work committee of the society of nuclear medicine to give support to express my heartfelt thanks, also put forward specific objectives for the work of the Commission, the advantage of integration in working committee under the leadership of deficiencies, guiding the discipline development plan, promote and guide the specification, radionuclide interventional therapy, coordinated multidisciplinary collaboration at the same time. The radionuclide therapy play a better role. At the same time working committee for the future development goals: short-term goal: 1. change the concept of unity of thinking; 2. to build the lighthouse, the lighthouse to the demonstration effect; screening 3. support units; 4. team and training of talents; promote the construction of 5. nuclear units. The medium-term goal: To summarize and generalize the 1. mode of development; build 2. standardized treatment and quality control; 3. integration advantages, make up the defects, coordinated multidisciplinary collaboration; 4. external promotion: to build brand influence; 5. radionuclide therapy in the treatment of MDT voice. Long term goal: to build a first-class radionuclide treatment platform in china.
Professor Huang Xuequan at the meeting discussed the iodine -125 particle implantation in the treatment of malignant tumor, and introduces the iodine -125 implantation in the treatment of the status quo at home and abroad, the importance of iodine -125 implantation in the treatment of standardization. Professor Yang Hui discusses interventional radionuclide therapy multidisciplinary the importance of cooperation on nuclear medicine and other departments to play a complementary role, make an important contribution to the promotion of interventional radionuclide therapy. Professor Chen Zhijun discussed the importance of nuclear medicine in interventional radionuclide therapy at the meeting and emphasized that nuclear medicine should strengthen its own level and play a greater role. Professor Li Zhi discussed the clinical application and development trend of individualized drug treatment at the meeting. Zeng Li associate professor at the meeting to discuss the precise target of refractory thyroid cancer treatment.
Outlook: the integration advantages, in the working committee under the leadership of deficiencies, guiding the discipline development plan, standardization, promotion, guide the radionuclide interventional therapy, coordinated multidisciplinary collaboration at the same time, the radionuclide therapy play a better role.
